Moorestown, NJ, United States of America

John G Callahan

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: John G Callahan: Innovator in Immunomodulating Topical Compositions

Introduction

John G Callahan is a notable inventor based in Moorestown, NJ (US). He has made significant contributions to the field of immunomodulating topical compositions, particularly in the treatment of skin infections and cancer. His innovative approach has led to the development of effective solutions for challenging medical conditions.

Latest Patents

John G Callahan holds 1 patent for his invention titled "Effective sensitizing dose of a gelled immunomodulating topical composition." This patent focuses on compositions and methods for treating warts and other human papilloma virus (HPV) skin infections, as well as skin cancer. His work in this area demonstrates a commitment to advancing medical treatments and improving patient outcomes.

Career Highlights

Throughout his career, John has worked with several prominent companies, including Phio Pharmaceuticals Corporation and Rxi Pharmaceuticals Corporation. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

John G Callahan has collaborated with notable professionals such as William R Levis and Leonard L Kaplan. These partnerships have enriched his work and expanded the impact of his inventions in the medical community.

Conclusion

John G Callahan's contributions to the field of immunomodulating topical compositions highlight his dedication to innovation and improving healthcare solutions. His patent and collaborations reflect a strong commitment to advancing medical science and addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…